Lundemose Anker Md, Ph.D, Dsc

Avg. Two Year Performance

No purchase track record

(< 1%) Avg. Sale Return

0% Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	3%	1%	1%	2%	(< 1%)
Sale Success Rate	6 of 10	4 of 10	4 of 10	4 of 10	0 of 10

OSI Pharmaceuticals Inc.

Drugs » Biotechnology

EVP, Corp. Dev & Strategic Pln:

Holdings: 0 shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--